Novel Gene Therapeutic Approaches to Brain Cancer

Maria Castro; James Curtin; Gwendalyn King; Gwendalyn King; Marianela Candolfi; Peter Czer; Sandra A. Sciascia; Kurt Kroeger; Sarah B. Honig; William Kuoy; Terry Kang; Stephen Johnson; Pedro R. Lowenstein

doi:10.21427/e3bq-qp57

Novel Gene Therapeutic Approaches to Brain Cancer

Maria Castro, James Curtin, Gwendalyn King, Gwendalyn King, Marianela Candolfi, Peter Czer, Sandra A. Sciascia, Kurt Kroeger, Sarah B. Honig, William Kuoy, Terry Kang, Stephen Johnson, Pedro R. Lowenstein

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.

Original language	English
Title of host publication	Gene Therapy for Neurological Disorders
Editors	Maria G. Castro, Pedro R. Lowenstein
Place of Publication	New York, NY
Publisher	Taylor & Francis Group, L.L.C.
Chapter	13
ISBN (Print)	978-0-8247-2847-2, 0-8247-2847-5
DOIs	https://doi.org/10.21427/e3bq-qp57
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21427/e3bq-qp57Licence: CC BY-NC-SA

Cite this

Castro, M., Curtin, J., King, G., King, G., Candolfi, M., Czer, P., Sciascia, S. A., Kroeger, K., Honig, S. B., Kuoy, W., Kang, T., Johnson, S., & Lowenstein, P. R. (2006). Novel Gene Therapeutic Approaches to Brain Cancer. In M. G. Castro, & P. R. Lowenstein (Eds.), Gene Therapy for Neurological Disorders Taylor & Francis Group, L.L.C.. https://doi.org/10.21427/e3bq-qp57

@inbook{677b6f838c514565a43d7f3e09f0fbb8,

title = "Novel Gene Therapeutic Approaches to Brain Cancer",

abstract = "In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.",

author = "Maria Castro and James Curtin and Gwendalyn King and Gwendalyn King and Marianela Candolfi and Peter Czer and Sciascia, \{Sandra A.\} and Kurt Kroeger and Honig, \{Sarah B.\} and William Kuoy and Terry Kang and Stephen Johnson and Lowenstein, \{Pedro R.\}",

year = "2006",

doi = "10.21427/e3bq-qp57",

language = "English",

isbn = "978-0-8247-2847-2",

editor = "Castro, \{Maria G.\} and Lowenstein, \{Pedro R.\}",

booktitle = "Gene Therapy for Neurological Disorders",

publisher = "Taylor \& Francis Group, L.L.C.",

}

TY - CHAP

T1 - Novel Gene Therapeutic Approaches to Brain Cancer

AU - Castro, Maria

AU - Curtin, James

AU - King, Gwendalyn

AU - Candolfi, Marianela

AU - Czer, Peter

AU - Sciascia, Sandra A.

AU - Kroeger, Kurt

AU - Honig, Sarah B.

AU - Kuoy, William

AU - Kang, Terry

AU - Johnson, Stephen

AU - Lowenstein, Pedro R.

PY - 2006

Y1 - 2006

N2 - In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.

AB - In the United States, approximately 17,000 people per year are diagnosed with brain tumors, the leading cause of death from cancers in children ages 1-15 year (1,2). Gliomas are the most prevalent type of brain tumors in adults, affecting 3.2/100,000 persons/yr in the United States (www.CBTRUS.org). In spite of advances in surgery, chemotherapy, and radiotherapy, the mean survival time of patients post-diagnosis remains approximately 9-12 months.

U2 - 10.21427/e3bq-qp57

DO - 10.21427/e3bq-qp57

M3 - Chapter

SN - 978-0-8247-2847-2

SN - 0-8247-2847-5

BT - Gene Therapy for Neurological Disorders

A2 - Castro, Maria G.

A2 - Lowenstein, Pedro R.

PB - Taylor & Francis Group, L.L.C.

CY - New York, NY

ER -

Novel Gene Therapeutic Approaches to Brain Cancer

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this